|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 750.51 USD | -0.23% |
|
-6.64% | -2.77% |
| 09-29 | Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says | MT |
| 09-28 | Pfizer's Tilrekimig Phase 3 Program Seen as Potential Upside Driver, UBS Says | MT |
| Market Cap | 74.94B 66.14B 62.58B 56.75B 106B 7,191B 107B 751B 289B 3,672B 281B 275B 11,817B | P/E 2026 * |
17.1x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 67.77B 59.81B 56.59B 51.32B 96.21B 6,503B 97.16B 679B 262B 3,321B 254B 249B 10,686B | EV / Sales 2026 * |
3.99x | EV / Sales 2027 * | 3.5x |
| Free-Float |
71.06% | Yield 2026 * |
0.52% | Yield 2027 * | 0.59% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.23% | ||
| 1 week | -6.64% | ||
| Current month | -6.08% | ||
| 1 month | -5.50% | ||
| 3 months | +18.79% | ||
| 6 months | +1.74% | ||
| Current year | -2.77% |
| 1 week | 741.83 |  | 807.2 |
| 1 month | 741.83 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
George Sing
BRD | Director/Board Member | 76 | 1988-01-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 9/2/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 8/19/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -6.64% | +33.84% | -8.80% | 75.12B | |
| +3.13% | +11.45% | +703.24% | +96.98% | 78.76B | |
| +1.41% | +3.16% | -6.71% | -24.95% | 61.14B | |
| -1.07% | -0.43% | -10.19% | +32.27% | 47.57B | |
| -2.68% | -3.14% | -9.14% | +166.70% | 46.07B | |
| -0.71% | +0.76% | +63.93% | -11.65% | 33.79B | |
| -1.30% | -2.94% | +46.86% | +113.26% | 25.3B | |
| -0.64% | -2.59% | +56.26% | +95.43% | 15.36B | |
| -0.96% | -4.71% | +26.96% | +150.17% | 13.02B | |
| +0.40% | +1.60% | -29.28% | +383.92% | 12.92B | |
| Average | -0.72% | -0.12% | +87.58% | +99.33% | 40.9B | |
| Weighted average by Cap. | -0.71% | +0.62% | +148.63% | +62.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.98B 14.98B 14.17B 12.85B 24.1B 1,629B 24.34B 170B 65.53B 832B 63.74B 62.36B 2,677B | 18.54B 16.36B 15.48B 14.04B 26.32B 1,779B 26.58B 186B 71.56B 908B 69.6B 68.09B 2,923B |
| Net income | 4.84B 4.27B 4.04B 3.66B 6.87B 464B 6.94B 48.46B 18.68B 237B 18.17B 17.77B 763B | 5.44B 4.8B 4.54B 4.12B 7.72B 522B 7.8B 54.5B 21.01B 267B 20.43B 19.99B 858B |
| Net Debt | -7.17B -6.33B -5.99B -5.43B -10.18B -688B -10.28B -71.84B -27.69B -351B -26.93B -26.35B -1,131B | -10.05B -8.87B -8.4B -7.61B -14.27B -965B -14.42B -101B -38.82B -493B -37.76B -36.93B -1,585B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$750.51 | -0.23% | 804,328 |
| 26-09-28 | US$752.25 | -4.54% | 1,149,832 |
| 26-09-25 | US$788.04 | -1.00% | 592,145 |
| 26-09-24 | US$796.02 | -0.72% | 602,653 |
| 26-09-23 | US$801.82 | -0.26% | 721,110 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
